Valuation: Treace Medical Concepts, Inc.

Market Cap 282M 250M 234M 213M 401M 27.11B 407M 2.83B 1.1B 13.81B 1.06B 1.03B 44.35B P/E 2026 *
-5.09x
P/E 2027 * -5.59x
Enterprise Value 327M 291M 272M 248M 466M 31.51B 473M 3.29B 1.27B 16.05B 1.23B 1.2B 51.54B EV / Sales 2026 *
1.58x
EV / Sales 2027 * 1.66x
Free-Float
74.43%
Yield 2026 *
-
Yield 2027 * -
1 day-1.96%
1 week-5.33%
Current month-4.05%
1 month-9.36%
3 months+1.19%
6 months+193.79%
Current year+73.88%
1 week 4.22
Extreme 4.22
4.63
1 month 4.22
Extreme 4.22
4.93
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
7.08
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
27.97
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 30/06/2013
Director of Finance/CFO 56 31/08/2020
Chief Tech/Sci/R&D Officer - 28/02/2022
Director TitleAgeSince
Chairman 54 19/05/2025
Director/Board Member 65 19/11/2020
Director/Board Member 68 19/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
24/08/26 Buy

Chief Executive Officer

11,000 0.0170%
09/08/26 Tax

Chief Financial Officer

-37,102 0.0572%
09/08/26 Tax

Responsable ventes & marketing

-9,814 0.0151%
Change 5-day change 1-year change 3-year change Capi.($)
-1.96%-5.33%-31.95%-65.89% 282M
-0.07%-5.09%-27.72%+0.42% 167B
+0.67%-2.19%-9.20%+11.48% 111B
+0.73%+0.79%-25.08%+0.24% 105B
+0.38%+0.90%-48.18%-11.28% 74.82B
-2.16%-0.96%-1.49%+69.73% 59.11B
-0.86%+2.96%+13.57%+59.50% 51.8B
-0.80%-3.62%-7.54%-31.27% 48.5B
+0.58%+0.26%-17.86%+20.81% 40.79B
-0.38%-1.27%+28.72%-9.55% 32.54B
Average -0.42%-0.60%-12.67%+4.42% 69.04B
Weighted average by Cap. -0.10%-0.91%-16.57%+9.74%

Financials

2026 *2027 *
Net sales 207M 184M 172M 157M 296M 19.98B 300M 2.08B 807M 10.17B 779M 762M 32.68B 222M 197M 184M 168M 316M 21.35B 320M 2.23B 863M 10.87B 833M 814M 34.92B
Net income -55.26M -49.09M -45.9M -41.83M -78.75M -5.32B -79.84M -555M -215M -2.71B -207M -203M -8.7B -51.01M -45.31M -42.37M -38.61M -72.69M -4.91B -73.69M -513M -198M -2.5B -192M -187M -8.03B
Net Debt 45.67M 40.56M 37.93M 34.57M 65.08M 4.4B 65.97M 459M 178M 2.24B 171M 168M 7.19B 86.44M 76.78M 71.8M 65.43M 123M 8.32B 125M 869M 336M 4.24B 325M 317M 13.61B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
02/10/26 US$4.260 -1.62% 32,247
01/10/26 US$4.330 -2.48% 183,058
30/09/26 US$4.440 -3.90% 157,606
29/09/26 US$4.620 +3.12% 141,679
28/09/26 US$4.480 -0.44% 169,562
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.330USD
Average target price
5.500USD
Spread / Average Target
+27.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock